High expression levels of cyclooxygenase-2 (COX-2) contribute a strong proliferative ability to human lung cancer cells, and this function is link to the epidermal growth factor receptor (EGFR) pathway, which was mediated by extracellular-signal-regulated kinase (ERK) and nuclear factor kappa B (NFκB). In this study, scutellarein, a flavonoid compound, was screened for proliferation inhibition at different concentrations (0, 5, 25 and 50 μM) at 24 h or 48 h in human lung cancer cell line A549. Results showed that A549 cell proliferation was inhibited by 50 μM scutellarein treatment in 24 h and 48 h of treatment. The expression levels of phosphorylated EGFR, phosphorylated ERK, phosphorylated NFκB and COX-2 were reduced in a dose-dependent manner after 24 h scutellarein treatments at different concentrations. Further, ERK inhibitor U0126 and NFκB inhibitor MG132 also inhibited A549 cell proliferation similar to 50 μM scutellarein treatment from 24 h to 48 h. The experimental results showed that scutellarein could inhibit proliferation of the human lung cancer cell line A549 through ERK and NFκB mediated by the EGFR pathway.
Introduction
Scutellarein is a compound that belongs to the flavonoids family with a structure similar to wogonin and baicalein (Fig. 1) . These flavonoids were reported to have antioxidant, anti-inflammatory and anti-tumor properties (5, 22) . While quick hydrolysis of flavonoids has been reported as revealed by high-performance liquid chromatography (HPLC) analysis, the primary metabolic compounds of scutellarein and scutellarein analogs preserve the original activities of the scutellarein (3, 14, 17, 21, 24) . A reasonable structure and activity relationship (SAR) of flavonoids can be attributed to the strong antioxidant activity induced by the hydroxyl groups on the A and B rings. On the other hand, the hydroxyl groups on the C rings of the flavonoids can provide a stronger anti-inflammatory activity and attenuate tumor necrosis factor α (TNF-α)-induced expression of adhesion molecules in human aortic endothelial cells (16, 25) . Inflammatory risks induced by smoking can be linked to the increase of nuclear factor kappa B (NFκB) and cyclooxygenase-2 (COX-2) activation, which in turn feedback and increase the expression of epidermal growth factor receptor (EGFR). Over-expression of EGFR activates COX-2 through the phosphorylation of extracellular-signal-regulated kinase (p-ERK) (19, 20) . This vicious circle increases the risk of lung cancer development in the smoking population (4, 6, 15) .
In this study, we tested the ability of scutellarein treatment with regard to the inhibition of proliferation of the A549 lung cancer cells. The inhibition of EGFR did not only decrease p-EGK expression, but also decreased the expression of NFκB and finally blocked COX-2 production as well as the vicious COX-2 feedback circle.
Materials and Methods

Chemicals
Scutellarein (Sigma, St. Louis, MO, USA) was dissolved in the mobiles phase solution (69% 60 mM phosphoric acid water solution and 31% acetonitrile, pH 3.2) and was analyzed by HPLC with ultraviolet detection using a C-18 column (Mightysil RP-18 GP column, Kanto, Iwiki, Japan) at a flow rate of 1.4 ml/min. Scutellarein was detected by UV detector (Shimazu, Kyoto, Japan) at 297 nm absorbance. The scutellarein purity was confirmed to be higher than 95%. The scutellarein stock solution for treatments was prepared by dissolving in dimethyl sulfoxide (DMSO) (Sigma) at 100 mM. When added to the culture medium, the scutellarein stock solution was diluted at least 1,000 times to prevent possible solvent side effects caused by DMSO. U0126 (Sigma) and MG132 (Sigma) were dissolved in DMSO at 10 mM as stock solutions, and U0126 and MG132 were diluted to 10 μM for cell treatments.
Cell Culture
The human lung cancer cell line A549, which was purchased from Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan, ROC), was grown to confluence in Dulbecco's minimum essential medium (Sigma) supplemented with 10% fetal bovine serum (Sigma), 2 mM glutamine, 1% nonessential amino acids (NEAA) and 1% antibiotic mixture (50 μg/ml of penicillin, 50 μg/ml of streptomycin and 10 μg/ml of neomycin/ml) at 37°C under 5% CO 2 humidified atmosphere. The cell density was administrated at 5 × 10 5 cells/10 cm dish.
Assessment of Cell Number
The 3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) protocol was used for assessment of cell viability and growth. A549 cells The culture supernatants were removed and 100 μl MTT (Sigma) in phosphate-buffered saline (1.2 mM, pH 7.4) was added to each well. After 4 h of incubation at 37°C, the MTT solution was removed and DMSO was added to dissolve the formazan crystals. The absorbance was set at 563 nm for reading using a Molecular Devices Flexstation3 (MDS Analytical Technologies, Mississauga, Canada). All the experiments were started at 5 × 10 5 cells seeded in 10-cm dishes and allowing 4 h for adhering. The cell number of all treatments in this work was calculated by the standard curve constructed from 0, 10, 20, 30, 40, 50 million cells seeded in 10-cm dishes.
Western Blot Analysis
Protein samples of A549 cells were collected after 48 h of scutellarein (0, 5, 25 and 50 μM) treatments (n = 3). SDS-PAGE using 12% acrylamide gels was then used to separate the proteins using 75 volt running for 3 h. The proteins were then transferred to Hybond-C membranes, following which the primary antibodies for EGFR (sc-80543, Santa Cruz Biotechnology, Dallas, Texas, USA), p-EGFR (#2231, Cell Signaling, Danvers, MA, USA), ERK (sc-271270, Santa Cruz), p-ERK (sc-136521, Santa Cruz), NFκB (sc-8414, Santa Cruz), p-NFκB (#3033L, Cell Signaling), COX-2 (sc-65239, Santa Cruz) and α-tubulin (sc-5286, Santa Cruz) were added onto the membranes. Finally, horseradish peroxidase-labeled antibodies were used and photos were taken with Fujifilm LAS-3000 (GE healthcare, Pittsburgh, Pennsylvania, USA).
Statistical Analysis
The results shown are means ± SD of three independent experiments. Statistical analysis was performed by one-way analysis of variants (ANOVA), Duncan's post-hoc test was been used after ANOVA analysis. For paired samples, the Student's t-test was applied. P values < 0.05 are considered statistically significant.
Results
Effects of Scutellarein on Cell Number
A549 cells were treated with scutellarein at 0, 5, 25 and 50 μM for 24 h and 48 h. Results revealed a dose-dependent decrease in cell number (Fig. 2) . At 50 μM concentration, scutellarein reduced cell proliferation most significantly from 24 h to 48 h, and 5 μM scutellarein also inhibited A549 cell proliferation after 48 h.
Effects of Scutellarein on Protein Expression
Following treatment of A549 cell line with 0, 5, 25 and 50 μM scutellarein for 24 h, the expression levels of EGFR, p-EGFR, ERK, p-ERK, NFκB, p-NFκB, COX-2 and α-tubulin were monitored by western blot analysis (Fig. 3) . The expression of p-EGFR, p-ERK, p-NFκB, COX-2 decreased in response to increasing scutellarein concentrations within 24 h.
ERK and NFκB Inhibition
p-ERK expression in A549 cells treated with the ERK inhibitor U0126 at 10 μM decreased effectively after 24 h. Downstream proteins such as p-NFκB and COX-2 also decreased following the down-regulation of ERK (Fig. 4A) . The p-NFκB expressions in A549 cells treated with the NFκB inhibitor MG132 at 10 μM also decreased efficiently after 24 h, as was the expression of the downstream COX-2, but the expression of the upstream ERK and p-ERK was unaffected by MG132 treatment (Fig. 4B) . Further, the cell proliferation effects of scutellarein (50 μM), U0126 (10 μM) and MG132 (10 μM) treatments in A549 cells from 24 h to 48 h were also investigated (Fig. 5) . The inhibitory effects on cell proliferation of scutellarein, U0126 and MG132 were similar from 24 h to 48 h, and maintained the cell number around 0.5 million which was the initial cell number before treatment.
Discussion
In this study, we found evidences to suggest that 48 h scutellarein treatment of the human lung cancer A549 cell line could effectively inhibit COX-2 expression as well as cell proliferation. Most importantly, scutellarein successfully decreased expression levels of p-ERK and p-NFκB, which are induced by EGFR activation and regulated by the MAPK pathway (1). This p-NFκB decreasing function was provided by the anti-inflammatory activity of scutellarein (7) . At the start of tumor formation, long-term state of the inflammatory reaction is one of the most considered reasons for rewire host energy metabolism in the tumor microenvironment (11) . Owing to this, scutellarein treatment might act as a potential anticancer agent through the inhibition of NFκB expression as shown in this study (3, 4, 6, 24) . Furthermore, we used ERK inhibitor U0126 and NFκB inhibitor MG132 to examine A549 cell proliferation and protein expression, and obtained similar results with scutellarein within 24 h to 48 h of treatment.
COX-2 could be induced by several pathways resulting in subsequent increases of cell proliferation. COX-2 was reported to be over-expressed in malignant tissues (2, 18, 26) . The human lung cancer cell line A549 was reported to be associated with not only over expression of COX-2, be also with that of ERK, JNK and p38 MAPK (8, 9, 12) . More importantly, COX-2 can feed back to increase EGFR expression, which aggravates the healthy conditions of the lung cancer patients (13) . Thus, inhibition of COX-2 expression may be a sound strategy in lung cancer therapy. The results of this study suggest that the effects of scutellarein treatment in lung cancer therapy are mediated through down-regulation of p-EGFR, p-ERK, p-NFκB and COX-2, and eventually blocking cell proliferation (10, 15, 23) . 
